We are live on ! Find out more
IART icon

Integra LifeSciences
IART

194 hedge funds and large institutions have $2.2B invested in Integra LifeSciences in 2016 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 88 increasing their positions, 62 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 12

42% more repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 62

4% more funds holding

Funds holding: 186 → 194 (+8)

4% more capital invested

Capital invested by funds: $2.12B → $2.2B (+$77M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
194
Holders Change
+8
Holders Change %
+4.3%
% of All Funds
5.17%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.11%
New
21
Increased
88
Reduced
62
Closed
12
Calls
$209K
Puts
–
Net Calls
+$209K
Net Calls Change
+$146K

Top Buyers

1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$25.4M
2
Deutsche Bank
Deutsche Bank
Germany
+$18.1M
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$16.5M
4
BJCM
Blue Jay Capital Management
California
+$11.2M
5
Artisan Partners
Artisan Partners
Wisconsin
+$9.81M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$51.5M
2
VNIM
Vaughan Nelson Investment Management
Texas
-$9.69M
3
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$8.26M
4
SCM
Snow Capital Management
Pennsylvania
-$5.1M
5
BPIM
Brant Point Investment Management
New York
-$4.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
SWA
176
Sutton Wealth Advisors
Florida
$15.8K +$14.6K +468 New
BL
177
Balentine LLC
Georgia
$14K – – –
Geode Capital Management
178
Geode Capital Management
Massachusetts
$13.7K +$453K +14,540 +4%
CSS
179
Cubist Systematic Strategies
Connecticut
$13K +$311 +10 +3%
US Bancorp
180
US Bancorp
Minnesota
$12K -$109K -3,502 -91%
WEC
181
Winslow Evans & Crocker
Massachusetts
$6.4K -$62 -2 -1%
VCM
182
Versant Capital Management
Arizona
$6K -$10.7K -344 -66%
KT
183
Kanaly Trust
Texas
$6K – – –
HNB
184
Huntington National Bank
Ohio
$6K +$5.61K +180 New
MFS
185
MSI Financial Services
Massachusetts
$4K – – –
CFG
186
Citizens Financial Group
Rhode Island
$3K – – –
N
187
Nuveen
North Carolina
$2.05K -$432K -13,882 -19%
GAM
188
Gemmer Asset Management
California
$2K – – –
UFA
189
US Financial Advisors
Massachusetts
$2K – – –
PMFA
190
Plante Moran Financial Advisors
Michigan
$2K +$2.18K +70 New
Barclays
191
Barclays
United Kingdom
$2K +$2.31K +74 New
S
192
SignatureFD
Georgia
$1K – – –
QCG
193
Quadrant Capital Group
Ohio
$1K +$1.18K +38 New
FC
194
FIC Capital
New York
– -$1.8M -53,266 Closed
ZCM
195
Zebra Capital Management
Connecticut
– -$832K -24,560 Closed
CCM
196
Cadence Capital Management
Massachusetts
– -$767K -22,640 Closed
QSS
197
Quantitative Systematic Strategies
Florida
– -$706K -20,656 Closed
DBG
198
De Burlo Group
Massachusetts
– -$370K -10,936 Closed
SIM
199
Strategic Investment Management
Virginia
– -$307K -9,066 Closed
Arrowstreet Capital
200
Arrowstreet Capital
Massachusetts
– -$203K -6,000 Closed
5 6 7
8
9

IART Hedge Fund Activity: Q1 2016 in Review

194 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q1 2016, worth a combined $2.2B — up 3.6% from $2.12B a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new IART positions and 12 closed out — a net gain of 9 holders — while 88 added to existing stakes and 62 trimmed.

The largest buyer was Lord, Abbett & Co, opening a new position worth an estimated $25.4M. The largest seller was Fidelity Investments, cutting an estimated $51.5M.

  • 194 institutional investors held Integra LifeSciences (IART) as of Q1 2016, up from 186 in Q4 2015.
  • Funds reported $2.2B of Integra LifeSciences stock for Q1 2016, up 3.6% quarter-over-quarter.
  • 21 funds opened new Integra LifeSciences positions in Q1 2016 and 12 closed out, a net change of +9 holders.
  • The largest Integra LifeSciences buyer in Q1 2016 was Lord, Abbett & Co, an estimated $25.4M added.
  • The largest Integra LifeSciences seller in Q1 2016 was Fidelity Investments, an estimated $51.5M sold.

Based on aggregated 13F filings for Q1 2016.